Rafael Stock Price

0.50 (1.33%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Rafael Holdings Inc RFL NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.50 1.33% 38.14 16:00:12
Open Price Low Price High Price Close Price Prev Close
37.72 36.50 38.40 38.14 37.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
627 33,658 $ 37.53 $ 1,263,343 43,659 11.44 - 52.87
Last Trade Time Type Quantity Stock Price Currency
19:00:00 2,278 $ 38.14 USD

Rafael Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 603.82M 15.83M 14.26M $ 3.58M $ - -0.66 -40.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 1.20%

more financials information »

Rafael News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RFL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week41.1242.1436.3939.4337,019-2.98-7.25%
1 Month43.8846.64536.3940.8244,218-5.74-13.08%
3 Months25.6352.8722.8737.6473,11712.5148.81%
6 Months17.1052.8715.0832.3052,35921.04123.04%
1 Year12.9152.8711.4426.7937,89325.23195.43%
3 Years18.3552.879.4023.9138,84819.79107.85%
5 Years18.3552.879.4023.9138,84819.79107.85%

Rafael Description

Rafael Holdings includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafael's pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs designed to enhance the efficacy of certain chemotherapeutic therapies.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.